Episode
Can the future of biopharma be greener, kinder and more human?
- Published
- May 11, 2025
- Duration seconds
- 1770
- Processing state
not_requested- Canonical source
- https://shows.acast.com/ey-nordics-fit-for-future-podcast/episodes/67f4d42d546af57906de856d
Actions
POST https://stenobird.com/v1/public/podcasts/ey-nordic-fit-for-future-podcast-7077399/episodes/can-the-future-of-biopharma-be-greener-kinder-and-more-human/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/ey-nordic-fit-for-future-podcast-7077399/can-the-future-of-biopharma-be-greener-kinder-and-more-human.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Biopharmaceutical sector is rethinking its role in shaping a healthier, more sustainable world. In this episode, host Jessica Schmidt welcomes Joseffa Moritz, Director Sustainability and Social Impact European Markets at Bristol Myers Squibb, and Daniel Brämhagen, EY Nordic People Sustainability Lead, for a deep dive into the industry’s shift toward greener, more human-centered care. Hosted on Acast. See acast.com/privacy for more information.